ProfileGDS5678 / 1415882_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 97% 97% 97% 97% 97% 97% 97% 97% 98% 97% 97% 97% 97% 97% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.1811597
GSM967853U87-EV human glioblastoma xenograft - Control 29.3736997
GSM967854U87-EV human glioblastoma xenograft - Control 39.4986697
GSM967855U87-EV human glioblastoma xenograft - Control 49.818597
GSM967856U87-EV human glioblastoma xenograft - Control 59.6674197
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.2297697
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.0877297
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.452397
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.6437198
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 19.5461997
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 29.1572597
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.4409197
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.39797
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.4364897